These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

616 related items for PubMed ID: 10830409

  • 1. Relationship among nigrostriatal denervation, parkinsonism, and dyskinesias in the MPTP primate model.
    Di Monte DA, McCormack A, Petzinger G, Janson AM, Quik M, Langston WJ.
    Mov Disord; 2000 May; 15(3):459-66. PubMed ID: 10830409
    [Abstract] [Full Text] [Related]

  • 2. α7 nicotinic receptor agonists reduce levodopa-induced dyskinesias with severe nigrostriatal damage.
    Zhang D, McGregor M, Bordia T, Perez XA, McIntosh JM, Decker MW, Quik M.
    Mov Disord; 2015 Dec; 30(14):1901-1911. PubMed ID: 26573698
    [Abstract] [Full Text] [Related]

  • 3. Prevention of levodopa-induced dyskinesias by a selective NR1A/2B N-methyl-D-aspartate receptor antagonist in parkinsonian monkeys: implication of preproenkephalin.
    Morissette M, Dridi M, Calon F, Hadj Tahar A, Meltzer LT, Bédard PJ, Di Paolo T.
    Mov Disord; 2006 Jan; 21(1):9-17. PubMed ID: 16127720
    [Abstract] [Full Text] [Related]

  • 4. Investigating levodopa-induced dyskinesias in the parkinsonian primate.
    Langston JW, Quik M, Petzinger G, Jakowec M, Di Monte DA.
    Ann Neurol; 2000 Apr; 47(4 Suppl 1):S79-89. PubMed ID: 10762135
    [Abstract] [Full Text] [Related]

  • 5. Relationship between the appearance of symptoms and the level of nigrostriatal degeneration in a progressive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned macaque model of Parkinson's disease.
    Bezard E, Dovero S, Prunier C, Ravenscroft P, Chalon S, Guilloteau D, Crossman AR, Bioulac B, Brotchie JM, Gross CE.
    J Neurosci; 2001 Sep 01; 21(17):6853-61. PubMed ID: 11517273
    [Abstract] [Full Text] [Related]

  • 6. The effects of chronic levodopa treatment on pre- and postsynaptic markers of dopaminergic function in striatum of parkinsonian monkeys.
    Rioux L, Frohna PA, Joyce JN, Schneider JS.
    Mov Disord; 1997 Mar 01; 12(2):148-58. PubMed ID: 9087972
    [Abstract] [Full Text] [Related]

  • 7. Effect of non-dopaminergic drug treatment on Levodopa induced dyskinesias in MPTP monkeys: common implication of striatal neuropeptides.
    Tamim MK, Samadi P, Morissette M, Grégoire L, Ouattara B, Lévesque D, Rouillard C, Di Paolo T.
    Neuropharmacology; 2010 Jan 01; 58(1):286-96. PubMed ID: 19576910
    [Abstract] [Full Text] [Related]

  • 8. Nicotine reduces levodopa-induced dyskinesias in lesioned monkeys.
    Quik M, Cox H, Parameswaran N, O'Leary K, Langston JW, Di Monte D.
    Ann Neurol; 2007 Dec 01; 62(6):588-96. PubMed ID: 17960553
    [Abstract] [Full Text] [Related]

  • 9. Nigrostriatal damage is required for induction of dyskinesias by L-DOPA in squirrel monkeys.
    Boyce S, Rupniak NM, Steventon MJ, Iversen SD.
    Clin Neuropharmacol; 1990 Oct 01; 13(5):448-58. PubMed ID: 2272024
    [Abstract] [Full Text] [Related]

  • 10. Effects of locus coeruleus lesions on parkinsonian signs, striatal dopamine and substantia nigra cell loss after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in monkeys: a possible role for the locus coeruleus in the progression of Parkinson's disease.
    Mavridis M, Degryse AD, Lategan AJ, Marien MR, Colpaert FC.
    Neuroscience; 1991 Oct 01; 41(2-3):507-23. PubMed ID: 1870701
    [Abstract] [Full Text] [Related]

  • 11. Chronic L-DOPA administration induces dyskinesias in the 1-methyl-4- phenyl-1,2,3,6-tetrahydropyridine-treated common marmoset (Callithrix Jacchus).
    Pearce RK, Jackson M, Smith L, Jenner P, Marsden CD.
    Mov Disord; 1995 Nov 01; 10(6):731-40. PubMed ID: 8749992
    [Abstract] [Full Text] [Related]

  • 12. Striatal Akt/GSK3 signaling pathway in the development of L-Dopa-induced dyskinesias in MPTP monkeys.
    Morissette M, Samadi P, Hadj Tahar A, Bélanger N, Di Paolo T.
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Apr 16; 34(3):446-54. PubMed ID: 20026151
    [Abstract] [Full Text] [Related]

  • 13. Levodopa-induced dyskinesia in MPTP-treated macaques is not dependent on the extent and pattern of nigrostrial lesioning.
    Guigoni C, Dovero S, Aubert I, Li Q, Bioulac BH, Bloch B, Gurevich EV, Gross CE, Bezard E.
    Eur J Neurosci; 2005 Jul 16; 22(1):283-7. PubMed ID: 16029219
    [Abstract] [Full Text] [Related]

  • 14. Primate model of parkinsonism: selective lesion of nigrostriatal neurons by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine produces an extrapyramidal syndrome in rhesus monkeys.
    Chiueh CC, Burns RS, Markey SP, Jacobowitz DM, Kopin IJ.
    Life Sci; 1985 Jan 21; 36(3):213-8. PubMed ID: 3871241
    [Abstract] [Full Text] [Related]

  • 15. Levodopa-induced dyskinesias in parkinsonian monkeys: relationship to extent of nigrostriatal damage.
    Schneider JS.
    Pharmacol Biochem Behav; 1989 Sep 21; 34(1):193-6. PubMed ID: 2576311
    [Abstract] [Full Text] [Related]

  • 16. Parkinsonian monkeys with prior levodopa-induced dyskinesias followed by fetal dopamine precursor grafts do not display graft-induced dyskinesias.
    Kordower JH, Vinuela A, Chu Y, Isacson O, Redmond DE.
    J Comp Neurol; 2017 Feb 15; 525(3):498-512. PubMed ID: 27418401
    [Abstract] [Full Text] [Related]

  • 17. Expression of D(3) receptor messenger RNA and binding sites in monkey striatum and substantia nigra after nigrostriatal degeneration: effect of levodopa treatment.
    Quik M, Police S, He L, Di Monte DA, Langston JW.
    Neuroscience; 2000 Feb 15; 98(2):263-73. PubMed ID: 10854757
    [Abstract] [Full Text] [Related]

  • 18. Unilateral MPTP-induced parkinsonism in monkeys. A quantitative autoradiographic study of dopamine D1 and D2 receptors and re-uptake sites.
    Przedborski S, Jackson-Lewis V, Popilskis S, Kostic V, Levivier M, Fahn S, Cadet JL.
    Neurochirurgie; 1991 Feb 15; 37(6):377-82. PubMed ID: 1780015
    [Abstract] [Full Text] [Related]

  • 19. The actions of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in animals as a model of Parkinson's disease.
    Jenner P, Marsden CD.
    J Neural Transm Suppl; 1986 Feb 15; 20():11-39. PubMed ID: 3091760
    [Abstract] [Full Text] [Related]

  • 20. Naloxone reduces levodopa-induced dyskinesias and apomorphine-induced rotations in primate models of parkinsonism.
    Klintenberg R, Svenningsson P, Gunne L, Andrén PE.
    J Neural Transm (Vienna); 2002 Oct 15; 109(10):1295-307. PubMed ID: 12373562
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.